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1078–5Objectives. An increasing number of aortoiliac lesions and abdominal aortic aneurysms occur in renal failure patients
waiting for renal transplantation. The aim of our study was to assess long term results of simultaneous renal transplan-
tation and surgical repair of aortoiliac lesions with arterial allografts.
Design. A retrospective observational study.
Patients and methods. From October 1997 to June 2007, we performed simultaneous aortoiliac reconstructions using
fresh arterial allografts and kidney transplantation in 14 patients with chronic renal failure (men 9, women 5, mean
age 53 years). The indication for vascular reconstruction was an asymptomatic abdominal aneurysm in 6 patients
or aortoiliac stenosis/occlusion in 8 patients. The median follow up period for the cohort was 55.5 months (range from
1 to 116 months).
Results. Three patients died during the follow up period. In none of them there was an allograft (neither arterial nor renal)
related death. No signs of arterial grafts infection or aneurysmal formation and no need for secondary intervention
(angioplasty and/or thrombolysis) of any arterial reconstruction was observed during the follow up period in any patient.
The renal grafts failed in three patients.
Conclusions. Our experience suggests that it is possible and safe to use arterial allografts in the treatment of arterial
occlusive disease or abdominal aortic aneurysm simultaneously with renal transplantation.
 2007 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
Keywords: Aortoiliac reconstruction; Kidney transplantation; Arterial transplantation; Arterial allografts; Abdominal
aortic aneurysm; Aortic allograft.Introduction
Improvements in the care of patients with end stage
kidney disease have resulted in increased number of
patients waiting for renal transplantation.1 Haemo-
dialysis and chronic renal failure are associated with
hypertension and lipid disorders that predispose to
accelerated atherosclerosis and many of potential
recipients suffer from aortoiliac atherosclerosis or
abdominal aortic aneurysms (AAA).2 The age and
number of comorbities of renal recipients is increasing
as well. Transplant surgeons therefore face a more fre-
quent need for vascular intervention prior to or simul-
taneously with the transplantation.1sponding author. I. Matia, MD, Department of Transplant
y, Institute for Clinical and Experimental Medicine, Videnska
, 140 21 Prague, Czech Republic.
address: ivmi@medicon.cz
884/000353 + 05 $34.00/0  2007 European Society for VasculaThere are few reports of simultaneous aortoiliac
vascular reconstruction and kidney transplanta-
tion.3e9 In all patients included, the vascular prosthe-
sis were used as conduits for arterial reconstruction
with varied success.
In our retrospective observational single-center study
we report the long term results of simultaneous renal
transplantation and aortoiliac reconstruction using
fresh arterial allografts obtained from the same donor.
Patients and Methods
The study was approved by our local ethical
committee.Patient population
From October 1997 to June 2007 1800 adult kidney
transplantations were performed at our Department.
In 14 renal graft recipients (0.7% of all kidneyr Surgery. Published by Elsevier Ltd. All rights reserved.
Table 1. Types of fresh arterial allografts used for vascular recon-
struction and specifications of renal transplantation procedures in
14 patients









1 Aortobiliofemoral 1 FAG
2 Aortobiliofemoral 2 FAG
3 Iliofemoral 1 FAG
4 Iliofemoral 1 FAG
5 Aortoiliac 1 FAG
6 Iliofemoral 1 FAG
7 Thoracic aorta 2 FAG
8 Iliofemoral 2 FAG
9 Thoracic aorta 1 EIA
10 Thoracic aorta 1 EIA
11 Thoracic aorta 2 EIA
12 Aortobiliofemoral 1 FAG
13 Aortobiliofemoral 1 FAG
14 Iliofemoral 3 FAG
FAG e fresh arterial allograft, EIA e external iliac artery.
354 I. Matia et al.transplantations) we simultaneously used fresh arte-
rial grafts as vascular conduits for aortoiliac recon-
structions. The mean age of patients, comprising 9
males and 5 females was 53 years (range 32 to 67
years). The median follow up period was 55.5 months
(range 1 to 116 months).
Three patients (21%) in this group had a previous
history of at least one unsuccessful renal transplanta-
tion with subsequent graftectomy. The aetiology of the
renal failure included renal arteries occlusion in 3
cases (21%), chronic pyelonephritis in 2 cases (14%),
glomerulonephritis in 2 cases (14%), vascular nephro-
sclerosis in 2 cases (14%), renal polycystosis in 2 cases
(14%), diabetic nephropathy in 1 case (7%), tubuloin-
testinal nephritis in 1 case (7%), and bilateral nephrec-
tomy due to Grawitz tumour in 1 case (7%). Of the
renal recipients, 12 (86%) were current or past
smokers, 7 (50%) had ischaemic heart disease, and 2
(14%) had diabetes.
In thirteen (93%) of the presented patients simulta-
neous aortoiliac reconstruction and renal transplanta-
tion was electively planned. The aortoiliac lesions
were preoperatively verified by angiography (conven-
tional or computed) and patients were put on a special
waiting list for renal transplant candidates.
An asymptomatic AAA was present in 6 cases
(46%). The median diameter of aneurysms was
53 mm (range 45 to 65 mm). Three patients were oper-
ated in the period before the endovascular treatment
of AAA was introduced at our Institute. Two were
not suitable for an endovascular procedure due to tor-
tuosity of the iliac vessels. One patient was operated
on 16 months after unsuccessful stentgraft implanta-
tion due to significant iliac occlusive disease.
Four patients (31%) with claudication presented
with bilateral iliac occlusions or stenoses not suitable
for endovascular treatment. All were selected for si-
multaneous aortobiiliac reconstruction and renal
transplantation.
One patient (8%) with unilateral claudications due
to iliac occlusion and one patient (8%) with toe gan-
grene due to prosthetic aortofemoral bypass occlusion
were selected for simultaneous aortofemoral bypass
and kidney transplantation. The renal artery was
anastomosed to the arterial allograft in both cases.
One patient (8%) who had received two failed renal
transplantations and also presented with a iliac occlu-
sion was selected for iliofemoral bypass to provide
a good blood supply for the renal graft transplanted
simultaneously.
An acute iliac artery resection and replacement due
to dissection during renal transplantation was per-
formed in one (7%) of fourteen presented patients.
The iliac allograft obtained from the same donor asEur J Vasc Endovasc Surg Vol 35, March 2008renal and liver grafts was used for the arterial substi-
tution. The iliofemoral grafts are obtained regularly
with liver but not renal grafts at our Institute.
Harvest and preservation of arterial grafts
All arterial and renal grafts were obtained from do-
nors with the diagnosis of cerebral death in the course
of a multiorgan harvest. The mean age of donors (14
males) was 31.5 years (range 15 to 44 years). Renal
and arterial grafts obtained from one donor were
both used in a single recipient.
After removal the arterial grafts were flushed with
conservation solutions used in renal harvest. The
grafts were then stored at a temperature of about 4 de-
grees Centigrade using the same types of solutions as
those used for flushing, with no additional antibiotics.
The mean cold ischemic time was 12.7 hours (range 5
to 24 hours) for arterial and 14.3 hours (range 7 to 26)
for renal grafts, respectively.
The types of arterial allografts obtained during
multiorgan harvest and used as conduits for vascular
reconstructions are summarized in Table 1.
Immunosuppressive therapy
The immunosuppressive protocol in patients with the
renal and arterial transplantations performed simulta-
neously did not differ from those used after a simple
renal transplantation at our department. In the case of
renal graft failure, the immunosuppression was re-
stricted to monotherapy with cyclosporine A or tacro-
limus as described previously.10
After arterial and renal transplantation patients
are carefully monitored by vascular surgeons and
355Aortoiliac Reconstruction with Kidney Transplantationnephrologists during the entire follow up period. The
patency of the arterial reconstructions was verified by
clinical examinations, ultrasonography and/or angi-
ography (conventional or computed), periodically
(Fig. 1). The function of transplanted kidneys and
level of immunosuppresive drugs are monitored in
accordance with our Institute’s standard policy stipu-
lating the level of care to be extended to organ
recipients.10Anticoagulants and antithrombotic drugs
In all but one patient acetylsalicylic acid was used as
an antithrombotic drug. In one patient after implanta-
tion of an aortic valve prosthesis warfarin was
prescribed.Results
There were three deaths (21%) during the follow up
period. Two patients died one month and 32 months,
respectively, after vascular reconstruction and renal trans-
plantation due to gastrointestinal (GIT) hemorrhage.Fig. 1. CT angiography 108 months after simultaneous aorto-
bifemoral bypass with arterial allograft and renal transplan-
tation in to left illiac fossa. The second renal transplantation
in to right iliac fossa was performed at 71 months after the
primary procedure. No sings of arterial allograft dilatation
or stenosis were seen during the all follow up period.
Arrows show proximal and distal anastomoses of arterial
aortobiliofemoral allograft.
The CT scan is published by permission of Department of
Radiology of Institute for Clinical and Experimental Medi-
cine in Prague.Another one died at 27 months due to intracerebral
hemorrhage. One patient was lost to follow up 60
months after operation. There was no arterial or re-
nal allograft related deaths in the presented group
of patients.
Three patients (21%) developed a problem with
wound healing. In two of them a wound dehiscence
required re-suturing and in another one a wound
lymph leak was treated conservatively. An ischemic
colitis with colon perforation developed in one patient
after a simultaneous abdominal aortic aneurysm
(AAA) repair and renal transplantation in the early
postoperative period. The inferior mesenteric artery
was ligated during the AAA resection. A subtotal co-
lectomy was undertaken 8 days after the primary op-
eration. Subsequently, an acute renal graft failure with
a short-term need for dialysis developed. The acute
rejection was successfully treated. No signs of arterial
allograft infection were noticed in this patient during
the subsequent follow up period.
No patient developed signs of arterial grafts infec-
tion, stenosis or dilatation of implanted allografts and
there was no need for secondary interventions (angio-
plasty and/or thrombolysis) during the follow up
period.
One primary renal allograft failure due to acute re-
jection with consecutive graftectomy occurred in one
patient. Renal allografts failed due to chronic rejection
in two (14%) other patients 62 and 96 months after
transplantation. In one of them a second renal trans-
plantation in the contralateral iliac fossa was per-
formed 71 months after the primary operation. The
renal artery was anastomosed to the arterial allograft.
This second renal allograft failed after 30 months due
to chronic rejection. Ureteral stenosis of transplanted
kidney was observed in two patients (14%) during
the first 6 months postoperatively. They were both
successfully treated by short-term percutaneous
nephrostomy.Discussion
The most suitable timing for vascular reconstruction
of aortoiliac vessels in renal recipients has been con-
troversial since the first successful renal artery anasto-
mosis to a vascular prosthesis was published by
Sterioff et al. in 1974.11 The first successful simulta-
neous aortoiliac prosthetic reconstruction and renal
transplantation was published in 1977 by Cerilli
et al.3 The main advantages of this one-stage proce-
dure summarised by Wright are: (1) there are no tech-
nical difficulties in the dissection due to reoperation;
(2) the cost and hospitalisation time are significantlyEur J Vasc Endovasc Surg Vol 35, March 2008
356 I. Matia et al.decreased; (3) the patient incurs only one anaesthetic
risk.5
However, the risk of prosthesis infection in immu-
nosuppressed patients is still present. The largest
series of patients with aortoiliac prosthetic reconstruc-
tion and renal transplantation performed as one-stage
procedure was recently published.9 During the four
years period a vascular graft was implanted in 11 re-
nal recipients. No infectious complications of the vas-
cular graft were noticed during this follow up period.
On the other hand Gouny et al.6 described one pa-
tient’s death due to prosthetic graft infection second-
ary to a urinary tract fistula in a group of two
patients with implanted bifurcated prosthetic grafts
during renal transplantation. A two-stage procedure
with intervals from 6 weeks to 3 months was recom-
mended by these authors. A vascular prosthesis infec-
tion was described in the work of Pittaluga et al. as
well.8 In addition, van der Vliet et al.,7 who evaluated
the outcome of renal transplantation with an arterial
anastomosis to a vascular prosthesis in 13 patients,
regards simultaneous renal transplant and arterial
reconstruction as hazardous with relatively poor
short- and long term results.
Arterial allografts have been successfully used in
the treatment of mycotic aneurysms and infected
vascular prostheses for last 20 years.12,13 Their good
resistance to infection was documented in the experi-
mental setting as well.14,15 No patient in our study de-
velop signs of arterial grafts infection. This finding
was despite one patient developing ischemic colitis
and colon perforation during the early postoperative
period.16
The immune response of recipient against antigens
in the arterial wall was confirmed in animals as well
as in humans studies.17,18 Aneurysm formation, mural
thrombosis, degenerative changes and occlusions have
been reported in the intermediate and long term follow
up of many patients after early clinical experience with
aortic allografts in the 1950s and 1960s.19e23 No immu-
nosuppression was used in these patients. Kieffer
et al.12 published in 2004 the study of fresh and cryo-
preserved arterial implantation for infrarenal aortic
graft infection in 179 patients. There were three allo-
graft-related late deaths from rupture of the allograft
and late nonlethal aortic events (occlusion, dilatation,
aneurysm) in 10 patients, respectively. The only signif-
icant risk factor for late aortic events was use of a tho-
racic aorta allograft. In addition, there were 63 late,
mostly occlusive, iliofemoral events. No immunosup-
pression was used in these patients. None of late aortic
or iliofemoral events mentioned above occurred in our
patients. In all cases immunosuppressive therapy was
prescribed during the follow up period.Eur J Vasc Endovasc Surg Vol 35, March 2008Important factors influencing the quality of fresh
arterial allografts are duration of conservation and
the type of conservation solution.24 In the study of
Szilagyi et al. published in 195725 the allograft were
harvested during donor autopsy with mean time
elapsed from death to autopsy of 10.1 hours. The
grafts were then stored in Hank’s solution for the
mean time of 25.8 days. Fresh arterial allografts used
by Kieffer et al.12 were obtained from brain dead do-
nors as part of a program to retrieve multiorgan trans-
plant tissue. The grafts were then stored in modified
RPMI 1640 Medium with addition of antibiotics and
heparin for the mean time of 13.0 days. In our study
all arterial allografts were stored in modern conserva-
tion solutions (Custodiol, University of Wisconsin,
Euro-Collins) used routinely in transplant medicine
with no addition of antibiotics and all were trans-
planted within 24 hours (mean 12.7 hours).
We conclude that renal transplantation and aortoil-
iac reconstruction with fresh arterial allografts can be
undertaken simultaneously as a one stage procedure
with satisfactory long term results of both renal and
arterial allografts. The good long term patency rates
of arterial allografts can be attributed to modern con-
servative solutions, short cold ischaemic times and
particulary the use of effective immunosuppression.Acknowledgement
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